Join
Live feed
·
INSIDERFilingvia Quantisnow
Intellia Therapeutics Inc. logo

EVP, Chief Financial Officer Dulac Edward J Iii sold $91,249 worth of shares (8,111 units at $11.25), decreasing direct ownership by 5% to 148,175 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NTLA (Intellia Therapeutics Inc.) and more on Quantisnow.